about
Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer's disease and amnestic mild cognitive impairment.MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progressionIndoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.Activating KIR/HLA complexes in classic Kaposi's SarcomaJC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients.B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.NCAM1 is the Target of miRNA-572: Validation in the Human Oligodendroglial Cell Line.Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication.A protective role for herpes simplex virus type-1-specific humoral immunity in Alzheimer's Disease.High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer's disease.Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer's disease.Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease.Continuous exposure to Kaposi sarcoma-associated herpesvirus (KSHV) in healthcare workers does not result in KSHV infection.Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients.Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.Markers of eosinophilic and neutrophilic inflammation in bronchoalveolar lavage of asthmatic and atopic children.How plausible is a link between HSV-1 infection and Alzheimer's disease?Serum iron concentration is associated with subcortical deep gray matter iron levels in multiple sclerosis patients.HSV-1-Specific IgG Subclasses Distribution and Serum Neutralizing Activity in Alzheimer's Disease and in Mild Cognitive Impairment.HLA alleles modulate EBV viral load in multiple sclerosis.A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary DiseaseSerum miRNAs Expression and SNAP-25 Genotype in Alzheimer's DiseaseThe PILRA G78R Variant Correlates with Higher HSV-1-Specific IgG Titers in Alzheimer's DiseaseImmunoglobulin Genes and Immunity to HSV1 in Alzheimer's DiseaseHerpes simplex virus type 1 and Alzheimer's disease: link and potential impact on treatmentHerpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patientsThe Biological Foundations of Sarcopenia: Established and Promising MarkersCirculatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's PatientsHSV-1-Specific IgG3 Titers Correlate with Brain Cortical Thinning in Individuals with Mild Cognitive Impairment and Alzheimer's Disease
P50
Q34341608-D278A88E-865B-4FA0-9C38-B137500B7A80Q35599410-611EC712-9BE3-43CD-B2A1-5EAA342C9EC4Q35674541-22AAF33A-D180-44C4-98AD-7260485A3451Q36048703-2CFE1D56-6818-4732-9DC5-828554E80983Q36572168-DAAEF54F-F009-43E1-BC16-A5F8EE95111CQ37093281-7289DB50-CEE0-4378-AA98-25287C8817E7Q38711097-69198F56-9CFD-42A3-9C7E-67936F9B244AQ39717911-3B425CB6-0A02-41D0-8D9E-2CC3E235A91AQ40459095-24CC07EA-EBF2-45B5-AAAA-AF2CAE0E7781Q40595931-687799C6-7D7E-4529-853C-BE0DBE0974F2Q40963016-C317B3F9-6B4E-41BE-BD5F-BB8C54CB4DFDQ41922958-9B5FEA24-8B79-448C-AB60-3113ECE6E0EEQ42275574-07F23037-D00A-4289-A142-1B2BC9C9FCE7Q42278928-1E63AA01-A916-4454-8AEF-168087BE9032Q42685726-9D8EEC5F-4D9C-4E8D-B821-F865479F2495Q44869530-3A3D40A8-A644-4F9A-B358-4015F131FF02Q51795171-E372BD69-1998-4AC9-A359-066C476CF0B1Q51850423-62B0D5BC-5790-4649-94CA-64B0A92162C3Q52094856-7148DD83-0144-4C92-88EC-69E73B8C8C3DQ54248555-6138697B-AFB1-49D8-816B-77F42A4CE323Q55017154-CFDE113A-650C-4EC5-9BAB-6BD65B3C5507Q62595374-AC7C9F9A-6A12-4979-BCFD-F9AE7FD95780Q64107132-44FAE6D9-F16D-4B3A-B220-B8FD0E77109BQ91815743-968789DB-ED87-416E-8C19-59C9731A126CQ91883738-9F7AF27C-D61B-4775-9C56-2D54B18FD78EQ92635023-DE219267-57D8-44E8-9E8E-B441E1CBA064Q92910570-C5550DF5-4546-4E29-A54B-FC9CBD69F8C1Q92923664-6531EEFA-5D58-4EBD-A972-37E020CAF2A2Q93116450-8EC47097-C5BC-4B7A-A806-B36005B99738Q96115306-8C4499C3-88B4-41F0-BA6F-2EE7F5E7B439
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Simone Agostini
@ast
Simone Agostini
@en
Simone Agostini
@es
Simone Agostini
@sl
type
label
Simone Agostini
@ast
Simone Agostini
@en
Simone Agostini
@es
Simone Agostini
@sl
prefLabel
Simone Agostini
@ast
Simone Agostini
@en
Simone Agostini
@es
Simone Agostini
@sl
P1053
L-7377-2015
P106
P1153
7006554114
P21
P2798
P31
P3829
P496
0000-0002-6214-0645